rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

STERIS plc (Ireland)

STE · NYSE

Health CareMedical DevicesAbove a falling average

STE stood above a rising 150-day average in 15 of the last 52 weekly readings, and has been out of that trend for the last 34 weeks. It is 6.4% above that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−2 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Above a falling average
Weeks in an uptrend
out for 34
Industry in uptrend
29% -2 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$13.1M
Officials’ trades on record
37
Institutions holding
771 (-11)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 15 of 52 weeks.

23 Apr – 22 Oct
18%29%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$6.3M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

37 disclosed lines: House 35, Senate 2, executive 0; 12 people.

WhoDidAmountTraded
Kevin Hern House: U.S. House ClerkOK01sold$15k–$50k15 Sep 2026filed 25 Sep 2026
April McClain Delaney House: U.S. House ClerkMD06solddependent child$100k–$250k25 Aug 2026filed 9 Sep 2026
April McClain Delaney House: U.S. House ClerkMD06solddependent child$1k–$15k31 Jul 2026filed 3 Aug 2026
April McClain Delaney House: U.S. House ClerkMD06solddependent child$1k–$15k29 Jul 2026filed 3 Aug 2026
April McClain Delaney House: U.S. House ClerkMD06solddependent child$1k–$15k27 Jul 2026filed 3 Aug 2026
April McClain Delaney House: U.S. House ClerkMD06solddependent child$1k–$15k24 Jul 2026filed 3 Aug 2026
Jared Moskowitz House: U.S. House ClerkFL23sold$1k–$15k13 Jul 2026filed 27 Aug 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k13 May 2026filed 8 Jun 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k11 May 2026filed 8 Jun 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k1 May 2026filed 8 May 2026
April McClain Delaney House: U.S. House ClerkMD06boughtdependent child$1k–$15k30 Apr 2026filed 6 May 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k29 Apr 2026filed 8 May 2026

Insiders

Buy orders, 12 months0
Sale orders, 12 months9
Buyers · sellers0 · 7
WhoDidSharesTraded
Mohsen SohiDirectorsold4,058at $235.7812 Aug 2026filed 12 Aug 2026
John Adam ZangerleSr. VP, Gen Counsel, and Sec.sold1,419at $209.2815 Jun 2026filed 16 Jun 2026
Daniel A. CarestioPresident and CEOsold1,374at $212.005 Jun 2026filed 8 Jun 2026
Daniel A. CarestioPresident and CEOsold3,054at $214.644 Jun 2026filed 8 Jun 2026
Richard C. BreedenDirectorsold1,481at $209.512 Jun 2026filed 4 Jun 2026
Cynthia L. FeldmannDirectorsold3,098at $237.215 Mar 2026filed 6 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders771-11 on the quarter
New · exited105 · 116
Reported value$19.1B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.reduced · filed 7 Aug 20268,820,889$1.9B-205,732−2.3%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20266,406,906$1.3B+40,528+0.6%
STATE STREET CORPadded · filed 7 Aug 20265,072,818$1.1B+80,950+1.6%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20265,001,950$1.1B+51,910+1.0%
MORGAN STANLEYreduced · filed 13 Aug 20263,950,067$831.8M-444,196−10.1%
MASSACHUSETTS FINANCIAL SERVICES COreduced · filed 3 Aug 20263,801,077$850.4M-209,272−5.2%
WELLINGTON MANAGEMENT GROUP LLPadded · filed 14 Aug 20263,502,897$737.6M+629,532+21.9%
Orbis Allan Gray Ltdadded · filed 14 Aug 20262,677,710$563.8M+84,798+3.3%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20262,615,842$548.6M+34,109+1.3%
GENERATION INVESTMENT MANAGEMENT LLPreduced · filed 10 Aug 20262,280,698$480.2M-27,761−1.2%
31 Mar 2023 – 30 Jun 2026
513666818Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Karen L. Burton Company insiderSr. Vice Pres., CFO · last 1 Oct 20260 · 8
Kevin Hern HouseOK01 · last 15 Sep 20260 · 1
April McClain Delaney HouseMD06 · last 25 Aug 20265 · 6
Mohsen Sohi Company insiderDirector · last 12 Aug 20260 · 7
Christopher S. Holland Company insiderDirector · last 10 Aug 20260 · 1
Cynthia L. Feldmann Company insiderDirector · last 10 Aug 20260 · 7
Esther M. Alegria Company insiderDirector · last 10 Aug 20260 · 0
Louis Shapiro Company insiderDirector · last 10 Aug 20260 · 0
Nirav R. Shah Company insiderDirector · last 10 Aug 20260 · 0
Paul Edward Martin Company insiderDirector · last 10 Aug 20260 · 0
Pierre Boulud Company insiderDirector · last 10 Aug 20260 · 0
Jared Moskowitz HouseFL23 · last 13 Jul 20261 · 1

Same industry

RCEL Avita MedicalLeading+127%
HTFL HeartflowLeading+57%
ATRC AtriCureLeading+54%
HAE HaemoneticsLeading+43%
BVS BioventusLeading+31%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2026 · to 31 Mar 202644.2%
Operating profit marginFY 2026 · to 31 Mar 202618.6%
Free cash flow marginFY 2026 · to 31 Mar 202616.4%
Return on capital employedFY 2026 · to 31 Mar 202611.5%
Cash conversionFY 2026 · to 31 Mar 2026171%
Debt to equityFY 2026 · to 31 Mar 20260.27×
Research spendFY 2026 · to 31 Mar 20261.9%
Share count trendFY 2026 · to 27 May 2026-0.2%
Cash and equivalentsFY 2026 · to 31 Mar 2026$439.6M
Free cash flowFY 2026 · to 31 Mar 2026$972.4M

Analyst forecasts

No analyst forecasts yet.